Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AGTR2 | P50052 | 20/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30195019 | 0.88 | AGTR2 (0.55) | AGTR2 | |
| SCHEMBL30195163 | 0.88 | AGTR2 (0.56) | AGTR2 | |
| SCHEMBL30195079 | 0.87 | AGTR2 (0.54) | AGTR2 | |
| SCHEMBL30195104 | 0.87 | AGTR2 (0.54) | AGTR2 | |
| SCHEMBL30194917 | 0.86 | AGTR2 (0.67) | AGTR2 | |
| SCHEMBL30195166 | 0.84 | AGTR2 (0.43) | AGTR2 | |
| SCHEMBL30194990 | 0.82 | AGTR2 (0.65) | AGTR2 | |
| SCHEMBL30970162 | 0.78 | AGTR2 (0.55) | AGTR2 | |
| SCHEMBL30970239 | 0.78 | AGTR2 (0.54) | AGTR2 | |
| SCHEMBL30970243 | 0.78 | AGTR2 (0.58) | AGTR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4367110-A1 | NEW SELECTIVE ANGIOTENSIN II COMPOUNDS | Vicore Pharma AB (SE) | 2024-05-15 | — | — | EP | claimed |
| CN-117916229-A | Novel selective angiotensin II compounds | 维科尔药物公司 | 2024-04-19 | — | — | CN | claimed |
| WO-2023281271-A1 | NEW SELECTIVE ANGIOTENSIN II COMPOUNDS | VICORE PHARMA AB (SE) | 2023-01-12 | — | — | WO | claimed |
| CN-117916229-A | Novel selective angiotensin II compounds | 维科尔药物公司 | 2024-04-19 | — | — | CN | disclosed |
| WO-2023281271-A1 | NEW SELECTIVE ANGIOTENSIN II COMPOUNDS | VICORE PHARMA AB (SE) | 2023-01-12 | — | — | WO | disclosed |